1 |
Huang XE, Tian GY, Cao J, et al (2013). Pemetrexed as a component of first-, second- and third-line chemotherapy in treating patients with metastatic lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 6663-7.
과학기술학회마을
DOI
ScienceOn
|
2 |
Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small celllung cancer patients. Asian Pac J Cancer Prev, 13, 301-4.
과학기술학회마을
DOI
|
3 |
Liu X-Y, Lai S-L, Guo X-F, Lao Y-R (2005). Shen-Mai injectionas an adjunct therapy to tumor chemotherapy a systematic review. Chinese J Evidence-Based Medicine, 1, 22-28.
|
4 |
Liu J, Huang XE, Tian GY, et al (2013). Phase II Study on safetyand efficacy of (Javanica oil emulsion injection) combined with chemotherapy for patients with gastric cancer. Asian Pac J Cancer Prev, 14, 2009-12.
과학기술학회마을
DOI
ScienceOn
|
5 |
Lo LC, Chen CY, Chen ST, et al (2012). Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlledtrial. Trials, 13, 232.
DOI
|
6 |
Qin CY, Maizhi Z (2000). Pattern, Cause, Pulse, and Treatment, Ancient Books of TCM, Beijing, China.
|
7 |
Shen B, Zheng MQ, Lu JW, et al (2013). CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancercells. Asian Pac J Cancer Prev, 14, 5403-8.
과학기술학회마을
DOI
ScienceOn
|
8 |
Shu JZ, Wang QR (2008). Meta analysis of the treatment for acute cerebral infarction with Shenmai injection andcompound salvia miltiorrhiza injection. Mod J Integ Trad Chin West Med, 17, 973-6.
|
9 |
Yu DS, Huang XE, Zhou JN, et al (2012). A comparative study on the value of anal preserving surgery for aged people with low rectal carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, 13, 2339-40.
과학기술학회마을
DOI
|
10 |
Zhan YP, Huang XE, Cao J, et al (2012). Clinical study onsafety and efficacy of (Cantharidin Sodium) injectioncombined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 4773-6.
DOI
ScienceOn
|
11 |
Zhang WL, Yan TH, Liu B, et al (2011). Systematic reviews and Meta-analysis of Shenmai injection with chemotherapy on treatment of patients with NSCLC. Practical Pharmacy and Clinical Remedies, 2, 95-101.
|
12 |
Zhang JH, Zhang G (2012). Clinical observation of Fufang Ban mao capsule for breast cancer patients neo-adjuvantchemotherapy. Chin J Clin Oncol Rehabil, 2-0147-03.
|
13 |
Gong P, Huang XE, Chen CY, et al (2012). Comparison oncomplications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pac J Cancer Prev, 13, 1873-5.
DOI
|
14 |
Deng QQ, Huang XE, Ye LH, et al (2013). Phase II Trial of (Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes. Asian Pac J Cancer Prev, 14, 413-7.
과학기술학회마을
DOI
ScienceOn
|
15 |
Bajsa J, Pan Z, Duke SO (2011). Transcriptional responses to cantharidin, a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple signaltransduction pathways. Physiol Plant, 143, 188-205.
DOI
ScienceOn
|
16 |
De Angelis V (2004). Activity, objective response, WHO and RECIST (Response Evaluation Criteria In Solid Tumor)evaluation criteria. Suppl Tumori, 3, 7-9.
|
17 |
Gupta D, Lis CG, Grutsch JF (2007). The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage, 34, 40-7.
DOI
|
18 |
Hsieh CH, Huang YC, Tsai TH, Chen YJ (2011). Cantharidin modulates development of human monocyte-deriveddendritic cells. Toxicol In Vitro, 25, 1740-7.
DOI
|
19 |
Huang SY, Cao KY (2010). Anti-invasive and anti-metastasis effect of norcantharidin on high-metastatic human breast cancer cell lines. J Trop Med, 9, 1034-45.
|
20 |
Huang XE, Wei GL, Huo JG, et al (2013). Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites. Asian Pac J Cancer Prev, 14, 2611-4.
과학기술학회마을
DOI
ScienceOn
|
21 |
Wang JY, Liu GJ (2009). Eflect of norcantharidin on theexpression of VEGF mRNA in human breast cancer cell lines. Chin Arch Trad Chin Med, 11, 2369-73.
|
22 |
Siegel R, Naishadham D, Jemal A(2013). Cancer statistics, 2013. CA Cancer J Clin, 11, 11.30.
|
23 |
Verma AK, Prasad SB (2012). Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma. Cell Biol Toxicol, 28, 133-47.
DOI
|
24 |
Wang J, Zhang L (2011). The clinical effect of TE chemotherapyregime, with Shenmai injection in the treatment of advancedbreast cancer. J Pharmaceutical Practice, 3, 184-95.
|
25 |
Wang Y, Ma KF, Zhang XG, Hu YZ, Shentu JZ (2011). Shenmai Injection in coronary heart disease patients: a systematicreview and Meta-analysis. Chinese J Hospital Pharmacy, 15, 1314-7.
|
26 |
Wu XY, Huang XE, You SX, et al (2013). Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer. Asian Pac J Cancer Prev, 14, 2019-22.
과학기술학회마을
DOI
ScienceOn
|
27 |
Xia CH, Sun JG, Wang GJ, et al (2010). Herb-drug interactions: in vivo and in vitro effect of shenmai injection, aherbal preparation, on the metabolic activities of hepaticcytochrome P450 3A1/2, 2C6, 1A2 and 2E1 in rats. Plant Medica, 76, 245-50.
DOI
|
28 |
Yan HA, Shen K, Huang XE (2013). Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4801-4.
과학기술학회마을
DOI
ScienceOn
|
29 |
Shi M, Shen Y (2012). Shenmai Injection for treatment of viral myocarditis: a meta-analysis. Chin Trad Patent Med, 10, 1882-6.
|